Special Offer! - Free Pharmacy Design - Limited Time Offer, Hurry Up & Register Now

My Cart
In stock

Wegovy 0.25 mg 1 Prefilled Pen 1.5ml

In stock
Only 1 left
SKU
10331011990

Wegovy 0.25 mg prefilled pen is a weekly injectable prescription medication for chronic weight management. It contains semaglutide, which helps reduce appetite and promotes feelings of fullness, supporting significant weight loss alongside diet and exercise. This starter dose helps your body adjust to the medication.

Product Details

Wegovy 0.25 mg prefilled pen is a prescription medication designed for chronic weight management in adults. It contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps regulate appetite and food intake. This medication is typically used in conjunction with a reduced-calorie diet and increased physical activity for adults with obesity (BMI ≥ 30 kg/m²) or who are overweight (BMI ≥ 27 kg/m²) with at least one weight-related comorbidity (e.g., high blood pressure, type 2 diabetes, or high cholesterol).

Benefits of Use

Significantly aids in weight loss and long-term weight management.
Helps improve weight-related health conditions such as high blood pressure and blood sugar levels.
Works by reducing appetite, increasing feelings of fullness, and slowing gastric emptying.

How to Use

  1. Always use Wegovy exactly as your doctor has told you.
  2. Administer Wegovy once weekly on the same day each week, at any time of day, with or without meals.
  3. Inject Wegovy subcutaneously (under the skin) in the abdomen, thigh, or upper arm.
  4. Rotate injection sites with each dose to avoid hardening of the skin.
  5. Follow a gradual dose escalation schedule as prescribed by your healthcare provider, starting with 0.25 mg once weekly for 4 weeks.
  6. Do not inject into a vein or muscle.
  7. Refer to the pen's instructions for use for detailed administration steps.

Caution & Warnings

  • Do not use if you or any of your family have a history of medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Inform your doctor if you have a history of pancreatitis or gallstones.
  • Patients may experience gastrointestinal side effects such as nausea, vomiting, diarrhea, or constipation, especially during dose escalation.
  • Monitor blood sugar levels if you are also taking insulin or sulfonylureas, as Wegovy can increase the risk of hypoglycemia.
  • Not recommended for use in patients with severe kidney problems or end-stage renal disease.
  • Discontinue use and seek medical attention if you experience severe abdominal pain, which could be a sign of pancreatitis.
  • Keep out of reach of children.
  • Do not share your Wegovy pen with others, even if the needle is changed, as this carries a risk of infection.

Ingredients

  • Active Ingredient: Semaglutide
  • Excipients: Disodium phosphate dihydrate, propylene glycol, phenol, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment), water for injection.
More Information
Gtin 05712249127862
Recommended Sale Price 481.45
Is Wasfaty Product No
Brand Wegovy
Ingredient Name SEMAGLUTIDE
SFDA Reg. No 2101256701
IBC 05712249127862
Drug Type Prescription
Scientific Name Semaglutide
Strength 0.25
Strength Unit mg
Form Solution for injection
Admin Route Subcutaneous
Size 1.5
Size Unit ml
Package Types Prefilled Pen
Package Size 1 Pen
shelfLife 24 months
Storage conditions Store in a refrigerator (2°C to 8°C). Do not freeze. After first use, store at room temperature (below 30°C) or in the refrigerator (2°C to 8°C) for up to 6 weeks.
Refrigerator Storage Yes